These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 21879275)
1. Screening for Lynch syndrome in colorectal cancer: are we doing enough? Canard G; Lefevre JH; Colas C; Coulet F; Svrcek M; Lascols O; Hamelin R; Shields C; Duval A; Fléjou JF; Soubrier F; Tiret E; Parc Y Ann Surg Oncol; 2012 Mar; 19(3):809-16. PubMed ID: 21879275 [TBL] [Abstract][Full Text] [Related]
2. Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Chang SC; Lin PC; Yang SH; Wang HS; Liang WY; Lin JK Surgery; 2010 May; 147(5):720-8. PubMed ID: 20045164 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Clendenning M; Sotamaa K; Prior T; Westman JA; Panescu J; Fix D; Lockman J; LaJeunesse J; Comeras I; de la Chapelle A J Clin Oncol; 2008 Dec; 26(35):5783-8. PubMed ID: 18809606 [TBL] [Abstract][Full Text] [Related]
4. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385 [TBL] [Abstract][Full Text] [Related]
5. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]
6. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
7. Yield of routine molecular analyses in colorectal cancer patients ≤70 years to detect underlying Lynch syndrome. van Lier MG; Leenen CH; Wagner A; Ramsoekh D; Dubbink HJ; van den Ouweland AM; Westenend PJ; de Graaf EJ; Wolters LM; Vrijland WW; Kuipers EJ; van Leerdam ME; Steyerberg EW; Dinjens WN; J Pathol; 2012 Apr; 226(5):764-74. PubMed ID: 22081473 [TBL] [Abstract][Full Text] [Related]
8. The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis. Alemayehu A; Tomkova K; Zavodna K; Ventusova K; Krivulcik T; Bujalkova M; Bartosova Z; Fridrichova I Neoplasma; 2007; 54(5):391-401. PubMed ID: 17688369 [TBL] [Abstract][Full Text] [Related]
9. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X; JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432 [TBL] [Abstract][Full Text] [Related]
10. Genetic testing for hereditary nonpolyposis colorectal cancer. Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209 [TBL] [Abstract][Full Text] [Related]
11. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers. Lawes DA; Pearson T; Sengupta S; Boulos PB Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253 [TBL] [Abstract][Full Text] [Related]
12. A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting. Ramsoekh D; Wagner A; van Leerdam ME; Dinjens WN; Steyerberg EW; Halley DJ; Kuipers EJ; Dooijes D Gut; 2008 Nov; 57(11):1539-44. PubMed ID: 18625694 [TBL] [Abstract][Full Text] [Related]
13. Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome. Lamba AR; Moore AY; Moore T; Rhees J; Arnold MA; Boland CR Fam Cancer; 2015 Jun; 14(2):259-64. PubMed ID: 25637498 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581 [TBL] [Abstract][Full Text] [Related]
15. Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter. Yearsley M; Hampel H; Lehman A; Nakagawa H; de la Chapelle A; Frankel WL Hum Pathol; 2006 Jul; 37(7):831-8. PubMed ID: 16784982 [TBL] [Abstract][Full Text] [Related]
16. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000 [TBL] [Abstract][Full Text] [Related]
18. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer. Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543 [TBL] [Abstract][Full Text] [Related]
19. Population-based screening for Lynch syndrome in Western Australia. Schofield L; Grieu F; Amanuel B; Carrello A; Spagnolo D; Kiraly C; Pachter N; Goldblatt J; Platell C; Levitt M; Stewart C; Salama P; Ee H; Raftopoulous S; Katris P; Threlfall T; Edkins E; Wallace M; Iacopetta B Int J Cancer; 2014 Sep; 135(5):1085-91. PubMed ID: 24474394 [TBL] [Abstract][Full Text] [Related]
20. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]